[
    "This trial is a phase 2/phase 3 study testing the efficacy of capecitabine, a chemotherapy drug, in treating metastatic breast cancer patients who meet certain eligibility criteria and do not have any exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for gastroesophageal reflux disease, testing the efficacy of rabeprazole and low dose tricyclic antidepressant as treatment options, with specific inclusion and exclusion criteria.",
    "This trial is a phase 2/phase 3 study testing the effectiveness of sodium valproate in treating peripheral neuropathic pain caused by diseases such as neuralgia, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for patients diagnosed with schizophrenia, testing the efficacy of three different doses of mp-214, with inclusion criteria of written informed consent, normal physical examination, and exclusion criteria of schizoaffective disorder, schizophreniform disorder, other psychotic disorders, or bipolar I or II disorder.",
    "The sample is a phase 2/phase 3 trial for unipolar depression, testing the efficacy of escitalopram and pindolol combination therapy and escitalopram monotherapy, with eligibility criteria including patients aged 18-65 with major depression and MADRS score of at least 25, and exclusion criteria including non-responders to escitalopram in the past and contraindications to the treatments.",
    "The sample is a phase 2/3 trial for anaplastic thyroid cancer, testing the efficacy of ca4p, paclitaxel, and carboplatin, with eligibility criteria including confirmation of diagnosis, prior treatment failure, and adequate organ function.",
    "This trial is testing the efficacy of aspirin, clopidogrel, and simvastatin in treating patients with TIA or minor acute ischemic stroke who are not candidates for acute thrombolysis or other acute intervention indicated as the current standard of care.",
    "The sample is a phase 2/phase 3 trial for metastatic breast cancer, testing the efficacy of trastuzumab and vinorelbine in patients with HER-2/neu overexpression, with inclusion criteria including confirmation of carcinoma of the breast, adequate hepatic, renal, and hematologic function, and exclusion criteria including prior therapy with vinorelbine and known hypersensitivity to trastuzumab or any component of the product.",
    "The sample is a phase 2/phase 3 trial for locally advanced and/or metastatic colorectal cancer, testing the efficacy of cpt-11 and ts-1 or cpt-11, 5-fu and l-lv, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for hypertension using olmesartan medoxomil and placebo, with inclusion criteria based on blood pressure levels and exclusion criteria including sensitivity to the drug and other medical conditions.",
    "The sample is a phase 2/phase 3 trial for ocular hypertension using bimatoprost as the drug, with inclusion criteria requiring a clinical diagnosis of glaucoma or ocular hypertension in both eyes and exclusion criteria including uncontrolled medical conditions and ocular seasonal allergies within the past 2 years.",
    "The sample is a phase 2/3 trial for Parkinson's disease, testing the efficacy of pramipexole immediate release and extended release in patients with L-DOPA therapy issues, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for seizures, with icd-10 codes provided, testing the efficacy of levetiracetam and lorazepam versus placebo and lorazepam, with inclusion criteria of seizure and exclusion criteria of pregnancy, renal failure, and hepatic impairment.",
    "This trial is testing the effectiveness of rasagiline and placebo in treating moderate to severe restless legs syndrome in patients who meet specific diagnostic criteria and are not currently receiving treatment for RLS, with a 30-day washout period required for participants on dopamine agonists or other therapies. Inclusion criteria also include being on a stable dose of certain antidepressants for at least 30 days prior to baseline visit, and female subjects must not be of childbearing potential or must agree to use contraception for the duration of the study. Exclusion criteria include a history of initial unresponsiveness to dopaminergic RLS treatment despite adequate dose of initial therapy, use of another MAO inhibitor within 30 days of baseline visit, and use of other drugs or supplements contraindicated with rasagiline.",
    "The sample is a phase 2/phase 3 clinical trial for rheumatoid arthritis testing the efficacy of sarilumab and methotrexate, with eligibility criteria including active disease and continuous treatment with MTX, and exclusion criteria including past non-response to TNF or biologic treatment and use of other DMARDs or biologic agents within a certain timeframe.",
    "The sample is a phase 2/phase 3 trial for small cell lung cancer, comparing carboplatin plus irinotecan to carboplatin plus etoposide, with inclusion criteria including cytological or histological proven SCLC Stage I or II at 1st diagnosis and no prior chemotherapy, and exclusion criteria including second malignancy and NYHA III.",
    "This trial is testing the efficacy of TG4010 and chemotherapy as a first-line treatment for non-small cell lung carcinoma patients with MUC1 antigen expression, with inclusion criteria including measurable lesions, adequate hematological, hepatic, and renal function, and performance status 0 or 1, and exclusion criteria including brain metastases, prior systemic therapy for advanced non-small cell cancer of the lung, and serious concomitant medical disorder.",
    "The sample is a phase 2/phase 3 trial for obesity, testing the drugs cp-945,598 and sibutramine, with inclusion criteria based on BMI and co-morbidities, and exclusion criteria based on blood pressure, diabetes, eating disorders, and use of appetite or weight modifying drugs.",
    "This sample is a phase 2/phase 3 trial for diabetic macular edema, testing the drug fluocinolone acetonide, with inclusion criteria including edema involving fixation and visual acuity of \u226520 and \u226468 letters by ETDRS in the study eye.",
    "The sample is a phase 2/phase 3 trial for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder, with inclusion criteria including admission to a psychiatric hospital within the previous 21 days, less than 15 years since first psychotic symptoms, and age 18-40 years, and the trial will test the efficacy of ethyl-eicosapentaenoic acid (EPA) and vitamins E + C.",
    "This is a phase 2/phase 3 trial for end stage renal disease patients receiving mycophenolate sodium delayed release tablets or mycophenolate mofetil, with eligibility criteria including negative T cell crossmatch and exclusion criteria including previous organ transplant or seropositivity for HIV, Hepatitis C or Hepatitis B virus antigenemia.",
    "This phase 3 trial is testing the efficacy of dronedarone and placebo in patients aged 70 or older with atrial fibrillation or atrial flutter, who have risk factors such as hypertension, diabetes, or prior cerebrovascular accident, and meet other eligibility criteria.",
    "The sample is a phase 3 trial for liver transplantation patients receiving immunosuppressive therapy with calcineurin inhibitors and corticosteroids, testing the efficacy of sirolimus and cyclosporine or tacrolimus, with inclusion criteria of age greater than 13 years and Cockcroft-Gault GFR values \u226540 mL/min and \u226490mL/min at screening.",
    "The sample is a phase 3 trial for Alzheimer's disease, testing the efficacy of rivastigmine transdermal patches in patients with a stable dose of donepezil, with inclusion criteria such as age over 50 and an MMSE score between 10 and 24, and exclusion criteria such as severe cardiovascular or respiratory disease, urinary obstruction, and active skin lesions.",
    "The sample is a phase 3 trial for bipolar disorder, testing the efficacy of ziprasidone oral capsule and placebo, with inclusion criteria of meeting DSM-IV criteria for Bipolar I Disorder and exclusion criteria of ultra rapid cyclers and significant cardiovascular disease, and the icd-10 codes for the diseases are provided.",
    "This is a phase 3 clinical trial for patients with congestive heart failure, testing the efficacy of dronedarone and placebo drugs, with specific inclusion and exclusion criteria based on heart conditions, illness, and medication history.",
    "This phase 3 trial is testing the efficacy of clofarabine, cytarabine, and placebo in treating relapsed or refractory acute myelogenous leukemia in patients over 55 years old, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for metastatic prostate cancer using chemotherapy (docetaxel and prednisone) as the drug, with eligibility criteria including confirmed diagnosis of adenocarcinoma of the prostate, unresponsiveness to hormone therapy, and experiencing cancer-related pain.",
    "This is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of lixisenatide, metformin, and sulfonylurea, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing tamoxifen and chemotherapy for patients with platinum and taxane-resistant ovarian, peritoneal, or fallopian tube cancer, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 trial for breast cancer patients who have undergone modified radical mastectomy and have histologically confirmed ER(-) PR(-) and HER-2(-) with positive axillary lymph nodes or negative axillary lymph node with age <35 years or \u2162 grade or intravascular cancer embolus, and the trial will test the efficacy of epirubicin, cyclophosphamide, paclitaxel, carboplatin, and g-csf as drugs.",
    "This phase 3 trial is testing erlotinib hydrochloride and pemetrexed disodium in patients with recurrent or advanced non-small cell lung cancer who have previously been treated with only one chemotherapy regimen, and have measurable disease and certain eligibility criteria.",
    "This is a phase 3 clinical trial for fibromyalgia and neurocognition, testing the efficacy of milnacipran and placebo, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for schizophrenia, testing the efficacy of asenapine and olanzapine compared to placebo, with inclusion criteria of acute exacerbation of schizophrenia and exclusion criteria of uncontrolled medical conditions or other primary psychiatric disorders.",
    "The sample is a phase 3 trial for HIV treatment, testing the efficacy of cobi, drv, and NRTIs in treatment-naive or experienced patients with specific eligibility criteria, including plasma HIV-1 RNA levels \u2265 1000 copies/mL and normal ECG, hepatic transaminases, and renal function.",
    "This phase 3 trial is testing the efficacy of asenapine and placebo in treating pediatric bipolar disorder, with strict inclusion and exclusion criteria including age, diagnosis, and medication history.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of drugs such as flutiform 250/10, skp-fluticasone, and flovent fluticasone hfa, with eligibility criteria including age, history of asthma, and documented use of inhaled corticosteroids, while exclusion criteria include life-threatening asthma, recent systemic corticosteroid medication, and significant non-reversible pulmonary disease.",
    "This phase 3 trial is testing the efficacy of telmisartan/amlodipine in treating uncontrolled hypertension in patients with diabetes or renal impairment who have been on stable antihypertensive medication for at least 6 weeks, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for gastroesophageal reflux disease in children aged 1-5 years, testing the efficacy of pantoprazole sodium enteric-coated spheroid, with inclusion criteria of endoscopically confirmed GERD and exclusion criteria of upper gastrointestinal anatomic or motor disorders, cow's milk allergy, and malignancy.",
    "This is a phase 3 clinical trial for bladder cancer using apaziquone and placebo drugs, with eligibility criteria including having transitional cell carcinoma of the bladder with clinically apparent tumor Ta, grade G1-G2, and exclusion criteria including having more than 5 bladder tumors or any single bladder tumor exceeding 3.5 cm in diameter.",
    "This phase 3 trial is testing the efficacy of aripiprazole, risperidone long acting injectable, and quetiapine in treating patients with schizophrenia or schizoaffective disorder who are stable but not optimally treated, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial testing idrabiotaparinux sodium, warfarin, and placebos for embolism and thrombosis, with specific inclusion and exclusion criteria.",
    "This is a phase 3 clinical trial for bipolar disorder, testing the efficacy of olanzapine, risperidone long acting injectable, and placebo, with eligibility criteria including confirmed diagnosis of bipolar I disorder, current manic or mixed episode, and a history of at least 2 bipolar mood episodes in the last year.",
    "The sample is a phase 3 trial for patients with HER2-positive metastatic or unresectable locally advanced/recurrent breast cancer, testing the efficacy of trastuzumab emtansine and treatment of physician's choice, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of empagliflozin and placebo drugs, with eligibility criteria including HbA1c levels and exclusion criteria including impaired renal function and liver disease.",
    "The sample is a phase 3 trial for idiopathic pulmonary fibrosis, testing the efficacy of ambrisentan and placebo, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the effectiveness of rituximab, fludarabine phosphate, and cyclophosphamide in treating chronic lymphocytic leukemia patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for overweight/obese individuals with type 2 diabetes mellitus, testing the efficacy of lorcaserin and placebo in reducing BMI, with inclusion criteria of BMI 27-45 kg/m2 and exclusion criteria of pregnancy, insulin use, symptomatic heart valve disease, and serious or unstable medical conditions.",
    "The sample is a phase 3 clinical trial for patients with type 2 diabetes, testing the efficacy of ly2189265, exenatide, metformin, and pioglitazone, with eligibility criteria including HbA1c levels and BMI range, and exclusion criteria including chronic insulin use and history of heart failure or pancreatitis.",
    "This phase 3 trial is testing the efficacy of golimumab, methotrexate, and placebo in treating rheumatoid arthritis patients who meet specific inclusion criteria, including having a diagnosis of RA for at least 3 months and active RA with at least 4 swollen and 4 tender joints, while excluding patients with certain inflammatory diseases, prior treatment with biologic anti-TNF drugs, and serious infections.",
    "This is a phase 3 trial for males with prostate cancer, testing the efficacy of leuprolide acetate as a medical androgen deprivation therapy, with inclusion and exclusion criteria listed.",
    "This trial is for a drug called ACR16, which will be tested on patients with Huntington's disease who meet specific inclusion criteria and do not meet any exclusion criteria. The trial is in phase 2/phase 3 and the drugs being tested are ACR16 10 mg, ACR16 22.5 mg, and ACR16 45 mg.",
    "This is a phase 3 trial for postmenopausal osteoporosis testing the efficacy of teriparatide, calcium supplement, and vitamin D supplement, with eligibility criteria including a minimum of one moderate or two mild atraumatic vertebral fractures and a hip or lumbar spine BMD measurement at least 1.0 standard deviation below the average bone mass for young, healthy women.",
    "This phase 3 trial is testing the efficacy of dexlansoprazole and lansoprazole in treating erosive esophagitis in patients who meet specific inclusion criteria, while excluding those with certain medical histories or who are taking certain medications.",
    "This phase 3 trial is testing the efficacy of buprenorphine transdermal system and placebo in treating moderate to severe chronic low back pain, with inclusion and exclusion criteria specified, and the disease being studied is low back pain.",
    "The sample is a phase 3 trial for hyperlipidemia using fenofibrate/simvastatin and pravastatin as drugs, with mixed dyslipidemia as the inclusion criteria and hypersensitivity to the drugs, pregnancy or lactation, contra-indication to the drugs, and unstable or severe cardiac disease as exclusion criteria.",
    "The sample is a phase 3 trial for the drug adalimumab in patients with active psoriatic arthritis who have had an unsatisfactory response or intolerance to at least two prior or ongoing DMARDs, with inclusion and exclusion criteria listed.",
    "This is a phase 3 clinical trial for patients with schizophrenia, testing the efficacy of cariprazine and placebo, with inclusion and exclusion criteria based on DSM-IV-TR criteria, SCIPANSS score, and physical examination, laboratory, vital signs, and ECG results.",
    "The sample is a phase 3 trial for fibromyalgia using milnacipran hydrochloride as the drug, with inclusion criteria based on ACR diagnosis and exclusion criteria including psychiatric illness, depression, and various medical conditions.",
    "The sample is a phase 3 trial for patients with osteoarthritis, hip or knee pain, and lower back pain, testing the effectiveness of oxycodone cr and tapentadol er as analgesics, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of formoterol turbuhaler\u00ae 4.5mg, formoterol turbuhaler\u00ae 9 mg, and turbuhaler\u00ae placebo, with inclusion criteria including males or females aged above 40 with a clinical diagnosis of COPD and current COPD symptoms, and exclusion criteria including a history and/or current clinical diagnosis of asthma or atopic diseases such as allergic rhinitis.",
    "This is a phase 3 trial for postmenopausal women with sexual dysfunction, testing the efficacy of tibolone and estradiol-norethisterone, with eligibility criteria including age, sexual activity, and BMI, and exclusion criteria including certain medications and medical conditions.",
    "The sample is a phase 3 trial for advanced non-small-cell lung cancer, testing the efficacy of pf-3512676 + paclitaxel + carboplatin and paclitaxel + carboplatin, with eligibility criteria including no prior systemic treatment for NSCLC and ECOG PS 0 or 1.",
    "The sample is a phase 3 trial for restless legs syndrome, testing xp13512 600mg, xp13512 1200mg, and placebo, with inclusion criteria based on the International RLS Study Diagnostic Criteria and exclusion criteria including sleep disorders, neurologic diseases, abnormal laboratory results, and pregnancy/lactation.",
    "The sample is a phase 2/phase 3 trial for macular edema associated with diabetes mellitus, testing standard of care and macugen drugs, with inclusion criteria of visual acuity between 20/50 and 20/200 and exclusion criteria of recent laser therapy in the eye, recent signs of uncontrolled diabetes, blood pressure worse than 160/100, and severe cardiac disease.",
    "This is a phase 3 trial for hypertension patients using nifedipine, with inclusion criteria being patients who completed the 8 week double blind treatment phase of Study 13176 and for whom the test drug is tolerable, and exclusion criteria being patients with expected difficulties for the continuous 1 year follow up.",
    "The sample is a phase 3 trial for locally advanced or metastatic prostate cancer using triptorelin (decapeptyl\u00ae) for 8 months followed by an extension study, with eligibility criteria including a confirmed diagnosis of prostate cancer and an estimated survival time of greater than 8 months.",
    "This phase 3 trial is testing the effectiveness of certoparin and unfractionated heparin in preventing thromboembolism in hospitalized medical patients aged 70 or older with acute medical illness and decreased mobility, and includes exclusion criteria such as prior major surgery or trauma, immobilization due to cast or fracture, and indication for anticoagulatory or thrombolytic therapy.",
    "The sample is a phase 3 trial for relapsing-remitting multiple sclerosis, testing the efficacy of fingolimod 1.25 mg, fingolimod 0.5 mg, and placebo, with inclusion criteria of patients between ages 18-55 with a diagnosis of multiple sclerosis and relapsing-remitting disease course, and exclusion criteria of other chronic diseases of the immune system, malignancies, acute pulmonary disease, cardiac failure, pregnant or nursing women, and other protocol-defined criteria.",
    "The sample is a phase 3 trial for the treatment of pharyngitis using celecoxib and placebo, with inclusion and exclusion criteria related to medication use and willingness to abstain from food and drink during certain periods, and the trial will use ICD-10 codes to identify patients with the disease.",
    "This phase 3 trial is testing the efficacy of oxycodone/naloxone controlled-release and placebo in treating chronic low back pain in subjects who meet specific inclusion criteria, including a stable opioid regimen and an average pain score of at least 5 on an 11-point numerical rating scale.",
    "The sample is a phase 3 trial for plaque-type psoriasis using secukinumab 150mg and 10mg/kg i.v. regimen, with eligibility criteria including achieving a partial response after twelve weeks of treatment with no major protocol deviations in a previous study, and exclusion criteria including ongoing use of prohibited psoriasis treatments and previous exposure to any biologic drug directly targeting IL-17 or the IL-17 receptor, except secukinumab in study CAIN457A2304.",
    "This phase 3 trial is testing the effectiveness of infliximab + methotrexate and methotrexate alone in treating psoriatic arthritis with peripheral polyarticular involvement, and has strict inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for asthma patients using budesonide/formoterol, with inclusion criteria of 18-65 years of age and presenting at a study emergency department with an asthma exacerbation, and exclusion criteria of admission to hospital and patients receiving more than 2000 \u00b5g/day of beclomethasone equivalent inhaled corticosteroids.",
    "The sample is a phase 3 trial for asthma with ciclesonide, placebo, and salbutamol as drugs, and the eligibility criteria include a history of asthma for at least 6 months and optimal use of MDI, while exclusion criteria include respiratory tract infection or asthma exacerbation within the last 30 days prior to entry into the study.",
    "The sample is a phase 3 trial for restless legs syndrome, testing the efficacy of gen (xp13512) and placebo, with inclusion and exclusion criteria based on the International RLS Study Group Diagnostic Criteria and excluding patients with sleep disorders or neurologic diseases, abnormal laboratory results, pregnant or lactating women, and women of childbearing potential who are not practicing an acceptable method of birth control.",
    "This phase 3 trial is testing the efficacy of fluticasone furoate versus placebo in treating perennial allergic rhinitis in children aged 6 to <15 years with a positive test response to house dust and/or dust mites on serum antigen-specific IgE antibody test, and a positive test result on nasal eosinophil count, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of tiotropium high and low dose compared to placebo in treating symptomatic asthma in patients between 12 and 17 years old who have been on maintenance treatment with an inhaled corticosteroid, and have confirmed diagnosis of asthma by bronchodilator reversibility, with a list of exclusion criteria.",
    "The sample is a phase 3 trial testing the efficacy of mk0653a, ezetimibe (+) simvastatin and atorvastatin in treating cardiovascular diseases and diabetes mellitus, with specific eligibility criteria for participants.",
    "This phase 3 trial is testing the efficacy of various drugs, including arformoterol tartrate inhalation solution and formoterol, in treating chronic obstructive pulmonary disease (COPD) in subjects with a smoking history and baseline breathlessness severity, while excluding subjects with asthma or other active/ongoing pulmonary conditions.",
    "The sample is a phase 3 trial for renal transplantation, testing the efficacy of cyclosporin a, belatacept less intensive regimen (li), and belatacept more intensive regimen (mi) as drugs, with specific inclusion and exclusion criteria for subjects.",
    "The sample is a phase 3 trial testing the effectiveness of capsaicin dermal patch in treating painful HIV-associated distal symmetrical polyneuropathy, with inclusion criteria including documented evidence of HIV-1 infection and a Screening Pain Sum Score of 12 to 36.",
    "The sample is a phase 3 trial for sickle cell disease using the drug ica-17043, with inclusion criteria including completion of a previous study and stable use of hydroxyurea, and exclusion criteria including pregnancy and unsuitability for long-term study.",
    "This phase 3 trial is testing the efficacy of sapropterin dihydrochloride, a drug used to treat phenylketonuria, and its eligibility criteria includes age, diagnosis confirmation, and willingness to comply with study procedures.",
    "This phase 3 trial is testing the effectiveness of CHOP regimen, carmustine, cyclophosphamide, doxorubicin hydrochloride, etoposide, prednisone, and vincristine sulfate in treating intermediate- or high-grade non-Hodgkin's lymphoma, with specific eligibility criteria for patients.",
    "The sample is a phase 3 trial testing the efficacy of escitalopram oxalate versus placebo in treating major depressive disorder in patients with various advanced stage cancers, and includes eligibility criteria for both disease and patient characteristics.",
    "The sample is a phase 3 trial for insomnia and bipolar disorder, testing the efficacy of ramelteon and placebo in patients with mild to moderate manic symptoms and clinically significant sleep disturbance, who are receiving at least 1 mood stabilizing medication, and meet certain inclusion and exclusion criteria.",
    "The sample is a phase 2/3 trial for impetigo, testing the effectiveness of experimental cd07223 1.5% topical gel bid and tid, as well as placebo comparator cd07223 vehicle gel bid and tid, with inclusion criteria including a clinical diagnosis of primary impetigo and a minimum diameter of target lesion of one centimeter, and exclusion criteria including use of systemic antibiotics or steroids within 14 days prior to study entry and presence of other active skin diseases at or near the target lesion area to be treated.",
    "The sample is a phase 3 trial for bipolar disorder and depression, testing the efficacy of lamotrigine regular and novel formulations in patients over 60 years old with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin and pioglitazone compared to placebo, with eligibility criteria including age and exclusion criteria including history of type 1 diabetes or recent antihyperglycemic therapy.",
    "This is a phase 2/phase 3 trial for benign prostatic hypertrophy, testing ozarelix/placebo and placebo drugs, with eligibility criteria including age, clinical signs and symptoms, IPSS score, peak urinary flow rate, and agreement not to use other BPH treatments. Exclusion criteria include history of prostate cancer, prior surgeries or radiation, and certain medication use.",
    "This phase 3 trial is testing the efficacy of insulin glargine, ly2189265, metformin, and glimepiride in treating type 2 diabetes not well controlled on 1, 2, or 3 oral antidiabetic medications, with inclusion and exclusion criteria specified.",
    "This is a phase 3 trial for chronic inflammatory demyelinating polyradiculoneuropathy, testing the efficacy of immune globulin iv (human) and albumin (human) 25%, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 3 trial is testing the efficacy of pazopanib and placebo in treating clear cell renal cell carcinoma, with eligibility criteria including prior systemic treatment and adequate organ function.",
    "This phase 3 trial is testing the efficacy of bendamustine at two different doses for patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic pain, testing the efficacy of oros hydromorphone and placebo in patients with osteoarthritis pain of the hip or knee who require daily opioid medication, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for depression and cognition, testing the efficacy of duloxetine and placebo, with inclusion criteria requiring a diagnosis of major depression and exclusion criteria including current or previous major psychiatric disorders other than depression and recent use of unapproved drugs.",
    "This is a phase 3 trial for patients with non-muscle invasive bladder cancer, testing the efficacy of epirubicin hydrochloride and mitomycin c, with eligibility criteria including disease characteristics, patient characteristics, and prior concurrent therapy.",
    "The sample is a phase 3 trial for post-traumatic stress disorder, testing the efficacy of quetiapine fumarate and its placebo, with inclusion criteria of patients having PTSD symptoms for at least 12 months and exclusion criteria of previous ineffective use of quetiapine or other anti-psychotics and taking prohibited medications.",
    "This phase 3 trial is testing the effectiveness of nifedipine (Adalat) in treating essential hypertension in Japanese patients who are already taking at least one antihypertensive drug, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for seasonal allergic rhinitis, testing the efficacy of mometasone furoate and placebo, with inclusion criteria including a positive skin-prick test response to an appropriate seasonal allergen and a 2-year documented history of SAR.",
    "The sample is a phase 3 trial for thromboembolism, testing the efficacy of dabigatran and warfarin as anticoagulants, with inclusion criteria of acute symptomatic DVT or PE and exclusion criteria of interruption of anticoagulant therapy for 2 or more weeks during the 3-12 months of treatment for the prior VTE, excessive risk of bleeding, elevated AST or ALT > 2x ULN, and severe renal impairment.",
    "This phase 3 trial is testing the efficacy of sildenafil citrate and alprostadil in treating male erectile disorder in patients undergoing BNS-RAP for prostate cancer, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of budesonide and fluticasone in treating bronchial asthma in 5-15 year olds who require treatment with inhaled steroids and have poorly controlled asthma, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for mipomersen and placebo in patients with Homozygous Familial Hypercholesterolemia (HoFH), with a list of related diseases and icd-10 codes, and eligibility criteria including stable lipid-lowering therapy, weight, and low-fat diet.",
    "This phase 3 trial is testing the efficacy of docetaxel and prednisone in treating patients with hormone-resistant prostate cancer, with eligibility criteria including progressive metastatic disease and prior failure of standard androgen deprivation therapy.",
    "This phase 3 trial is testing the efficacy of doxorubicin, cyclophosphamide, and docetaxel in treating large resectable or locally advanced breast cancer with measurable disease, and eligible patients must meet certain criteria including age, performance score, and adequate organ function.",
    "The sample is a phase 3 trial for patients with bipolar disorder and depression, testing the efficacy of quetiapine fumarate (Seroquel\u2122) as a mood stabilizer, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for patients with metastatic renal cell carcinoma, testing the efficacy of sorafenib and temsirolimus, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of cisplatin and gemcitabine hydrochloride in treating unresectable locally advanced, recurrent, or metastatic extrahepatic bile duct and gallbladder cancer patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for schizophrenia and schizoaffective disorder using lurasidone hcl as the drug, with inclusion criteria requiring completion of a previous study and exclusion criteria including BMI and risk of harm to self or others.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of aprepitant and placebo, with eligibility criteria being patients with Major Depressive Disorder and icd-10 codes including F33.0, F33.1, F33.9, F32.0, F32.1, F32.9, and F33.40.",
    "This is a phase 3 trial for patients with gastrointestinal stromal tumor, testing the efficacy of imatinib mesylate as a treatment option, with eligibility criteria including histologically confirmed tumor, complete resection of primary tumor, and meeting specific disease and patient characteristics.",
    "This phase 3 trial is testing the efficacy of rolofylline and placebo in treating heart failure patients with specific inclusion and exclusion criteria, including dyspnea, fluid overload, and BNP levels, among others.",
    "The sample is a phase 3 trial for untreated metastatic colorectal carcinoma, testing the efficacy of bevacizumab, erlotinib, and low dose capecitabine, with eligibility criteria including age, measurable disease, and adequate organ function.",
    "The sample is a phase 3 trial for osteoporosis, testing the efficacy of odanacatib, placebo, vitamin D3, and calcium supplement, with eligibility criteria including postmenopausal status, BMD t-score, and exclusion criteria including previous hip fracture and treatment with certain bone-affecting agents.",
    "The sample is a phase 3 trial for osteoporosis using zoledronic acid as the drug, with specific inclusion and exclusion criteria, and a list of icd-10 codes for the disease.",
    "The sample is a phase 3 trial for preladenant and placebo in patients with idiopathic Parkinson's disease who have been on a stable dopaminergic treatment regimen for at least 5 weeks and are experiencing motor fluctuations with or without dyskinesias, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of fentanyl buccal tablets in treating breakthrough pain associated with chronic pain conditions such as cancer, diabetic peripheral neuropathy, and fibromyalgia, in patients who are already on stable doses of around-the-clock opioid therapy.",
    "This phase 3 trial will test the efficacy of soluble ferric pyrophosphate (sfp) in treating chronic renal failure requiring hemodialysis, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for type 2 diabetes using vildagliptin and placebo, with inclusion criteria of not currently on drug therapy for type 2 diabetes and meeting blood glucose criteria, and exclusion criteria of history of type 1 diabetes, significant diabetic complications, and serious cardiovascular events within the past 6 months.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of placebo/teneli + pio and teneli/teneli + pio drugs, with inclusion criteria including age, HbA1c levels, and previous use of Thiazolidinedione, and exclusion criteria including type 1 diabetes, serious diabetic complications, and pregnancy/lactation.",
    "The sample is a phase 3 trial for chronic hepatitis B using telbivudine as the drug, with inclusion criteria requiring completion of a previous qualifying Idenix-Sponsored trial with telbivudine and exclusion criteria including pregnancy or co-infection with hepatitis C, hepatitis D or HIV.",
    "The sample is a phase 3 trial for sleep disorders, testing the efficacy of zolpidem and zolpidem mr, with inclusion criteria of nonorganic insomnia and exclusion criteria of allergic reactions to zolpidem and serious cardiac, hepatic, or renal disorders.",
    "This phase 3 trial is testing the efficacy of GSK1349572 and raltegravir, both antiretroviral drugs, in INI-na\u00efve HIV-1 infected adults with resistance to two or more classes of antiretroviral agents.",
    "The sample is a phase 3 trial for oral contraception with the drugs ee20/drsp (bay86-5300) and ee20/drsp (yaz, bay86-5300), targeting diseases such as contraception, ovulation inhibition, and contraceptives, oral, with inclusion criteria for healthy women between 18 and 45 and exclusion criteria for the use of steroidal oral contraceptives or any drug that could alter oral contraception metabolism.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of ly2189265, sulfonylureas, biguanides, alpha-glucosidase inhibitor, thiazolidinedione, and glinides, with eligibility criteria including a qualifying HbA1c value of 7.0% to 11.0% and a BMI of 18.5 to 35.0 kg/m^2.",
    "This is a phase 3 trial for patients with generalized anxiety disorder, testing the efficacy of duloxetine hydrochloride compared to placebo, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of truvada/raltegravir in treating HIV infection in patients who meet specific eligibility criteria, including having a CD4 cell count >50 cells/mm3 and being on a stable ART with at least 3 licensed agents, one of which being EFV, for at least 12 weeks at screening.",
    "This is a phase 3 clinical trial for the treatment of schizophrenia using paliperidone, with specific inclusion and exclusion criteria, and the use of ICD-10 codes to identify the disease.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of qva149, nva237, qab149, and placebo, with inclusion criteria including age, smoking history, and diagnosis of moderate to severe COPD, and exclusion criteria including respiratory tract infection, concomitant pulmonary disease, and certain cardiovascular co-morbid conditions.",
    "The sample is a phase 3 trial for patients diagnosed with schizophrenia, testing the efficacy of paliperidone er, with inclusion criteria including PANSS score of 80 to 120 and exclusion criteria including substance dependence and serious medical conditions.",
    "The sample is a phase 3 trial for patients with atrial fibrillation and vascular risk, testing the efficacy of clopidogrel (sr25990c) as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 clinical trial is testing the efficacy of Aricept (donepezil) in treating Alzheimer's disease, with specific inclusion and exclusion criteria for patients and caregivers.",
    "This phase 3 trial is testing the efficacy of sitagliptin, an antidiabetic drug, on patients with type 2 diabetes mellitus who are experiencing inadequate glycemic control, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for colorectal cancer patients, testing the efficacy of capecitabine, fluorouracil, and oxaliplatin, with specific eligibility criteria including tumor location and stage, as well as various health requirements.",
    "The sample is a phase 3 trial for patients with moderate to severe COPD, testing the efficacy of drugs including nva237, tiotropium, and salbutamol/albuterol, with inclusion criteria based on FEV1 and smoking history, and exclusion criteria including pregnancy and certain medical conditions.",
    "The sample is a phase 3 clinical trial for major depressive disorder, testing the efficacy of saredutant, escitalopram, and placebo, with inclusion criteria for outpatients with recurrent MDD and exclusion criteria for mild depression, suicide risk, lack of sexual activity, and other psychiatric conditions.",
    "This phase 3 trial is testing the effectiveness of tacrolimus, methotrexate, and sirolimus in treating acute and chronic leukemias and myelodysplastic syndromes in patients with a 6/6 HLA-matched sibling donor, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for major depressive disorder, testing the effectiveness of quetiapine sr and escitalopram, with inclusion criteria of age and diagnosis, and exclusion criteria of other Axis I or II disorders and duration of depression episode, with icd-10 codes provided; while the second example is a study testing the ability of extended release nifedipine to decrease the dose of glucocorticoid medication in children with congenital adrenal hyperplasia.",
    "The sample is a phase 3 trial for various types of soft tissue sarcoma, using vincristine sulfate, cyclophosphamide, and topotecan hydrochloride as drugs, with specific eligibility criteria for patients to be included in the trial.",
    "The sample is a phase 3 trial testing the efficacy of droxidopa, a drug used to treat orthostatic hypotension, in patients with Parkinson's disease and symptomatic neurogenic orthostatic hypotension, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of ly2605541 and insulin glargine as a treatment, with eligibility criteria including a stable dose of oral antihyperglycemic medications and a hemoglobin A1c less than or equal to 9.0%.",
    "The sample is a phase 2/phase 3 trial for the treatment of schizophrenia with the drugs cyp-1020 and risperidone, with eligibility criteria including recent onset of symptoms and a sufficient clinical response to a previous course of anti-psychotic medication.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin phosphate and placebo as drugs, with inclusion criteria based on laboratory results for HbA1c and FPG.",
    "The sample is a phase 3 trial for mitiglinide, a drug used to treat type 2 diabetes, with inclusion criteria including stable metformin usage and HbA1c levels between 7.5% and 10.5%, and exclusion criteria including chronic insulin use and recent use of oral diabetic agents.",
    "The sample is a phase 3 trial for head and neck cancer patients with inclusion criteria such as a performance status of 0-2, normal liver/kidney/blood cell function, and willingness to participate, and exclusion criteria such as previous treatment for cancer that has spread, serious sickness, and certain types of cancer. The trial will test the effectiveness of pemetrexed, cisplatin, and placebo as drugs.",
    "The sample is a phase 3 trial for restless legs syndrome, testing the efficacy of various doses of ropinirole IR and CR, with inclusion criteria based on IRLSSG diagnostic criteria and exclusion criteria including intolerance to ropinirole or other dopamine agonists, and prohibited medications, among others.",
    "The sample is a phase 3 trial for myocardial infarction using clopidogrel, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing cisplatin and fluorouracil for nonmetastatic anal cancer patients with specific disease characteristics and patient characteristics, and no prior biologic, chemotherapy, endocrine therapy, or pelvic or inguinal radiotherapy.",
    "The sample is a phase 3 clinical trial for the treatment of grass allergy with various drugs, including loratadine and prednisone, and eligibility criteria including a positive skin prick test and specific IgE response to Phleum pratense, and exclusion criteria such as severe asthma and allergy to investigational medicinal products.",
    "The sample is a phase 3 trial for patients with chronic hepatitis B and cirrhosis, testing the effectiveness of ldt (telbivudine) and lamivudine, with eligibility criteria including age range of 18 to 70 years old.",
    "The sample is a phase 3 trial for Parkinson's disease, testing the efficacy of safinamide and placebo, with inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for patients with active acromegaly, treated with Octreotide LAR, testing the efficacy of lanreotide (autogel formulation) for 24-56 weeks, with inclusion criteria based on IGF-1 and GH levels, and exclusion criteria based on recent pituitary surgery or radiotherapy.",
    "The sample is a phase 3 trial for epilepsy patients using pregabalin as the drug, with inclusion criteria of a diagnosis of epilepsy with partial seizures and exclusion criteria of early withdrawal from the previous protocol, an episode of status epilepticus, or primary generalized epilepsy.",
    "This phase 3 clinical trial is testing the efficacy of docetaxel and vandetanib in treating locally advanced or metastatic non-small cell lung cancer patients who have had 1st line anti-cancer therapy, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the drugs cnto 1275 and etanercept for the treatment of psoriasis in patients who have failed to respond to or cannot use cyclosporine, methotrexate, or psoralen plus ultraviolet light A, and have a PASI score of 12 or greater and a PGA score of 3 or greater, with inclusion criteria including a diagnosis of plaque-type psoriasis at least 6 months prior to the study and plaque-type psoriasis covering at least 10% of total body surface area.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of montelukast sodium and placebo, with inclusion criteria of acute asthma and exclusion criteria of women of childbearing age and history of COPD.",
    "The sample is a phase 3 trial for major depressive disorder with inadequate response to one antidepressant, testing the efficacy of tc-5214 compared to placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the drug mitiglinide, with inclusion criteria of inadequate control of blood glucose and exclusion criteria of type 1 diabetes, insulin treatment, severe diabetic complications, severe hepatic or renal diseases, severe hypertension or cardiac disease, and pregnancy or possibility of pregnancy during the study period.",
    "The sample is a phase 3 trial testing the efficacy of febuxostat and allopurinol in preventing tumor lysis syndrome in patients with hematologic malignancies, with specific inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of lifitegrast and placebo in treating dry eye disease, with inclusion criteria including patient-reported history of dry eye in both eyes and recent artificial tear use, and exclusion criteria including any ocular condition that could affect study parameters and history of LASIK or similar type of corneal refractive surgery within 12 months prior to first visit.",
    "The sample is a phase 3 clinical trial for lapatinib and paclitaxel in patients with gastric carcinoma who have received one prior regimen, with specific eligibility criteria including disease type, prior treatment, organ function, and exclusion criteria such as concurrent therapy or serious medical disorders.",
    "This phase 3 trial is testing the efficacy of erlotinib, cisplatin, and gemcitabine in treating advanced non-small cell lung cancer patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for psoriasis, testing the efficacy of clobetasol propionate spray and calcitriol ointment, with inclusion criteria of moderate to severe plaque psoriasis and exclusion criteria of involvement of certain areas, such as the scalp and groin.",
    "This phase 3 trial is testing the efficacy of simvastatin and placebo in treating acute optic neuritis in patients between 18 and 59 years old with abnormal contrast sensitivity scores and symptom duration maximum 4 weeks, who do not have optic neuritis earlier in the same eye, are not pregnant or nursing, and do not have certain medical conditions or take certain medications. The trial involves patients with optic neuritis and multiple sclerosis, and the icd-10 codes for these diseases are included in the table.",
    "The sample is a phase 3 trial for severe hypertension using valsartan plus hydrochlorothiazide as the drug, with inclusion and exclusion criteria listed, and the disease being studied is hypertension.",
    "This phase 3 trial is testing the efficacy of eptifibatide and placebo in patients with stable or unstable angina pectoris and multivessel disease, requiring implantation of two DES in overlapping with a total stent length > 33 mm and reference vessel diameter between 2.5 and 4.0 mm, with exclusion criteria including ongoing or recent episode of unstable coronary artery disease, serum creatinine >2.5 mg/dl or with a creatinine clearance <40mL/min, ongoing serious bleeding or bleeding diathesis, and previous stroke in the last 6 months.",
    "This phase 3 trial is testing the efficacy of mabthera/rituxan and methotrexate in treating rheumatoid arthritis in patients who have had an inadequate response or intolerance to at least 1 anti-TNF alpha therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the treatment of perennial allergic rhinitis, testing the efficacy of beclomethasone dipropionate hydrofluoroalkane hfa nasal aerosol compared to placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for advanced stage non-small-cell lung carcinoma, testing the efficacy of afatinib and erlotinib as 2nd line therapy, with eligibility criteria including measurable disease, adequate performance status, and availability of tumour tissue material for correlative studies.",
    "The sample is a phase 3 trial for non-small cell lung cancer, testing the efficacy of gemcitabine and carboplatin, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease, testing the efficacy of qva149, tiotropium, and salbutamol/albuterol, with inclusion criteria including moderate to severe COPD and a smoking history of 10 pack years, and exclusion criteria including a history of long QT syndrome and any history of asthma.",
    "This phase 3 trial is testing the efficacy of bupropion hydrochloride sustained release and placebo in treating major depressive disorder, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with advanced idiopathic Parkinson's disease, testing the efficacy of ropinirole prolonged release and ropinirole immediate release, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with hypercholesterolemia and dyslipidemia, testing the efficacy of pitavastatin, with inclusion criteria including completion of a previous study and following a fat and cholesterol restrictive diet, and exclusion criteria including abnormal pancreatic, liver, or renal function and significant heart disease.",
    "The sample is a phase 3 trial for the treatment of migraine disorders using sumatriptan succinate, with inclusion and exclusion criteria listed, and the diseases are specified as migraine disorders with corresponding ICD-10 codes.",
    "This phase 3 trial is testing the effectiveness of methylprednisolone in patients aged 18 or younger with kidney diseases who have undergone a kidney transplant, and are on triple immunosuppression with cyclosporine, MMF, and daily steroids, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of ipragliflozin, placebo, and pioglitazone, with specific inclusion and exclusion criteria.",
    "This trial is a phase 2/phase 3 study for breast cancer patients with distant metastases or inoperable locally advanced disease, testing the efficacy of capecitabine and hormonal treatment (tamoxifen, exemestane, anastrozole or letrozole) with specific eligibility criteria.",
    "The sample is a phase 3 trial for ankylosing spondylitis, testing the efficacy of golimumab and placebo, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for postmenopausal symptoms, testing the efficacy of brisdelle (paroxetine mesylate) and placebo capsules, with inclusion criteria including age, frequency of hot flashes, and menopausal status, and exclusion criteria including previous non-response to SSRI or SNRI treatment, history of depression or borderline personality disorder, and use of investigational study medication.",
    "The sample is a phase 3 clinical trial for multiple sclerosis, testing the efficacy of fingolimod and placebo, with inclusion criteria of patients aged 18-55 with relapsing-remitting disease course and EDSS score of 0-5.5, and exclusion criteria of other chronic diseases, malignancies, and pregnancy or nursing.",
    "This is a phase 3 trial for chronic obstructive pulmonary disease (COPD) patients, testing the efficacy of indacaterol and salmeterol compared to placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with atrial fibrillation and cardioembolic risk factors, testing the effectiveness of indobufen and aspirin as drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of propiverine hydrochloride er and ir in treating neurogenic urinary bladder disorder, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for idiopathic pulmonary fibrosis, testing the efficacy of pirfenidone and placebo drugs, with eligibility criteria including age, lung function, and ability to walk, and exclusion criteria including certain medical conditions and withdrawal from other IPF trials.",
    "This phase 3 trial is testing the efficacy of darunavir/ritonavir and raltegravir or darunavir/r and tenofovir/emtricitabine in treating HIV infections in patients who have not received antiretroviral drugs before and have a CD4 cell count \u2264 500/mm3, with a list of inclusion and non-inclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus using rosiglitazone (brl49653c) and includes eligibility criteria such as adequate blood, liver and kidney function, and exclusion criteria such as serious cardiovascular or hepatic disease.",
    "This phase 3 clinical trial will test the efficacy of Sativex and placebo in treating central neuropathic pain due to multiple sclerosis, with inclusion criteria including a pain score of four or more on the Numerical Rating Scale and a stable medication regime for neuropathic pain.",
    "The sample is a phase 3 trial for bladder cancer patients, testing the efficacy of cephalexin and ciprofloxacin drugs, with eligibility criteria including disease stage and patient characteristics, and restrictions on prior and concurrent therapies.",
    "This phase 3 trial aims to test the efficacy of citalopram hydrobromide in reducing bothersome hot flashes in postmenopausal women with a history of breast cancer or those who refused estrogen replacement therapy, with a list of eligibility criteria and concurrent therapy restrictions.",
    "The sample is a phase 3 trial for Japanese patients with type 2 diabetes mellitus, testing the efficacy of bi 1356 and voglibose in reducing HbA1c levels, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for elderly subjects with psychosis, testing the drug asenapine, with inclusion criteria of psychosis and exclusion criteria of uncontrolled medical conditions or established dementia.",
    "This trial is for adult patients with acute myelogenous leukemia (AML) and unfavorable risk cytogenetics in first or subsequent complete remission, testing the drug decitabine, with inclusion criteria including performance status and organ function, and exclusion criteria including pregnancy, HIV positivity, and recent investigational therapy.",
    "The sample is a phase 3 clinical trial for patients with soft tissue sarcoma, testing the efficacy of ombrabulin and placebo drugs, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for breast cancer patients who have received prior treatment with anthracycline and taxane, and are now being treated with ixabepilone + capecitabine or capecitabine, with eligibility criteria including no history of brain and/or leptomeningeal metastases and no prior treatment with epothilones and/or capecitabine.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of exenatide and taspoglutide, with eligibility criteria including age, HbA1c levels, BMI, and stable weight, and exclusion criteria including history of type 1 diabetes, diabetic complications, and abnormal clinical laboratory tests or ECG.",
    "This phase 3 trial is testing the efficacy of fixed-dose combinations of telmisartan and amlodipine in treating essential hypertension, with a list of exclusion criteria including pregnancy, renal impairment, and known hypersensitivity to the medications.",
    "The sample is a phase 3 trial for the drug aripiprazole in treating serious behavioral problems in children with autistic disorder, with inclusion and exclusion criteria specified, and the disease and drug values are 'autistic disorder' and 'aripiprazole', respectively.",
    "The sample is a phase 3 trial for multiple sclerosis, testing the efficacy of teriflunomide and placebo, with inclusion criteria including relapsing clinical course and meeting McDonald's criteria for MS diagnosis, and exclusion criteria including use of certain immunosuppressant agents before enrollment.",
    "This phase 3 trial is testing the efficacy of ly2605541 and insulin glargine in combination with insulin lispro for type 2 diabetes mellitus patients with specific eligibility criteria, including a hemoglobin A1c value between 7.0% and 12.0%, a body mass index \u226445.0 kg/m^2, and access to a method of communication with the site.",
    "The sample is a phase 3 trial for patients with schizophrenia, testing the efficacy and tolerability of Seroquel SR as an antipsychotic drug, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of insulin degludec and insulin glargine in combination with stable oral antidiabetic therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for Parkinson's disease using istradefylline (kw-6002) as the drug, with inclusion and exclusion criteria listed.",
    "This is a phase 3 trial for gastroesophageal reflux disease, testing the efficacy of dexlansoprazole mr and placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of ipragliflozin, metformin, and placebo, with inclusion criteria of patients receiving metformin mono-therapy for at least 6 weeks, HbA1c value between 7.0 and 9.5%, and BMI between 20.0 and 45.0 kg/m2, and exclusion criteria of type 1 diabetes mellitus patients, serum creatinine > upper limit of normal, estimated GFR < 60ml/min/1.73m2, proteinuria, dysuria and/or urinary tract infection, genital infection, significant renal, hepatic or cardiovascular diseases, and severe gastrointestinal diseases.",
    "The sample is a phase 3 trial for sepsis, testing the effectiveness of metoclopramide, zinc, and selenium, with eligibility criteria including age and medical devices, and exclusion criteria including allergies and previous enrollment.",
    "This phase 3 trial is testing the efficacy of lanreotide autogel 120 mg, a somatostatin analogue, in treating acromegaly, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of laquinimod, a drug used to treat multiple sclerosis, in patients with relapsing-remitting MS who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of sorafenib and placebo in patients with hepatocellular carcinoma who meet specific inclusion criteria, while excluding those with certain medical histories or conditions.",
    "This is a phase 3 trial for patients with brain edema or brain tumor, testing the efficacy of hcrf and placebo hcrf drugs in reducing peritumoral brain edema, with inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for HER2-negative breast cancer patients who progressed during or after first-line treatment with Avastin and chemotherapy, testing the combination of bevacizumab and chemotherapy as a second-line treatment option.",
    "The sample is a phase 3 trial for major depressive disorder, testing the effectiveness of paroxetine and lithium, with inclusion criteria including a DSM-IV diagnosis of major depression and a positive family history of bipolar disorder or completed suicide, and exclusion criteria including current or prior adequate trial of lithium or paroxetine, and current use of other medications such as antidepressants for the treatment of depression.",
    "This is a phase 3 trial for diabetic macular edema using ranibizumab and sham to ranibizumab, with inclusion criteria including visual acuity impairment, diabetic macular edema, and stable diabetes medication for the last 3 months.",
    "This phase 3 trial is testing the efficacy of gemcitabine plus ts-1, ts-1, and gemcitabine in treating advanced unresectable pancreatic cancer with specific eligibility criteria, including age, ECOG performance status, and organ function.",
    "The sample is a phase 3 trial for psoriasis using etanercept as the drug, with inclusion criteria of male and female patients aged 18-70, and exclusion criteria of healthy volunteers.",
    "The sample is a phase 3 clinical trial for the treatment of hepatitis C virus using a combination of drugs including asunaprevir, daclatasvir, pegylated-interferon alfa 2a, and ribavirin, with specific eligibility criteria for patients including HCV genotype 1b, previous treatment failure with peginterferon alfa and ribavirin, and HCV RNA \u2265 10,000 IU/mL.",
    "This phase 3 trial is testing the efficacy of desvenlafaxine succinate sustained-release and escitalopram in postmenopausal women with major depressive disorder, with specific inclusion and exclusion criteria based on age, diagnosis, and medical history.",
    "The sample is a phase 3 trial for schizophrenia and schizoaffective disorders, testing the effectiveness of olanzapine, amantadine, metformin, and zonisamide, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for patients with moderate to severe atopic dermatitis, testing the effectiveness of tacrolimus ointment, with inclusion and exclusion criteria including drug history and medical conditions.",
    "The sample is a phase 3 trial for the drug zd6474 (vandetanib) in patients with unresectable, locally advanced or metastatic hereditary or sporadic Medullary Thyroid Cancer, with inclusion criteria of confirmed diagnosis and presence of measurable tumor, and exclusion criteria of major surgery within 4 weeks before randomization, last dose of prior chemotherapy received less than 4 weeks prior to randomization, radiation therapy within the last 4 weeks prior to randomization, brain metastases or spinal cord compression, unless treated at least 4 weeks before first dose and stable without steroid treatment for 10 days, significant cardiac events, and previous ZD6474 treatment.",
    "The sample is a phase 3 trial for multiple myeloma and plasma cell neoplasm, testing the efficacy of prednisone and thalidomide in patients who have undergone autologous stem cell transplantation, with eligibility criteria including specific disease characteristics and patient characteristics such as age, performance status, and hematopoietic, hepatic, renal, cardiovascular, and pulmonary health.",
    "The sample is a phase 3 trial for primary insomnia, testing the efficacy of zolpidem-mr, zolpidem, and placebo, with inclusion criteria based on DSM-IV criteria.",
    "The sample is a phase 3 trial for recurrent ovarian cancer using carboplatin and cisplatin, with eligibility criteria including prior chemotherapy and specific patient characteristics.",
    "The sample is a phase 3 trial for colorectal cancer using cetuximab and folfox, with inclusion criteria requiring availability of FFPE tumor sample for miR-31-3p and miR-31-5p expression testing.",
    "The sample is a phase 3 trial for chronic pain using oxymorphone extended release as the drug, with specific inclusion and exclusion criteria, and a list of associated icd-10 codes.",
    "The sample is a phase 3 trial for patients with healed reflux esophagitis, testing the efficacy of esomeprazole and omeprazole, with inclusion and exclusion criteria related to previous treatment and ulcers.",
    "The sample is a phase 3 trial for patients with myocardial infarction, testing the efficacy of bivalirudin and unfractionated heparin as treatments, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for chronic kidney disease stage 5 patients on dialysis, testing the efficacy of fosrenol and sevelamer hydrochloride, with exclusion criteria including gastrointestinal disorders, pregnancy or nursing, current use of lanthanum carbonate, sevelamer hydrochloride, or cinacalcet hydrochloride, HIV positivity, and clinical significant liver disease.",
    "This phase 3 trial is testing the efficacy of armodafinil and placebo in treating major depressive episodes in patients with bipolar I disorder, who are taking certain mood stabilizers, and meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for Parkinson's disease using ropinirole as a drug, with inclusion criteria including modified Hoehn and Yahr Scale Stages II-IV and lack of control with L-dopa therapy, and exclusion criteria including dementia and participation in other investigational drug studies.",
    "This phase 3 trial is testing the efficacy of oxycodone naloxone and oxycodone pr tablets in treating cancer and non-cancer pain with opioid-related constipation, with inclusion criteria including patients aged 18 or older, currently receiving a WHO step II or III opioid, and having a KESS score \u2265 9 or current use of laxatives.",
    "The sample is a phase 3 clinical trial for painful diabetic peripheral neuropathy, testing the efficacy of pregabalin versus placebo, with inclusion and exclusion criteria based on pain severity and previous pregabalin treatment, and the presence of unrelated neurologic disorders.",
    "The sample is a phase 3 trial for early rheumatoid arthritis, testing the efficacy of methotrexate and methotrexate placebo, with inclusion and exclusion criteria based on disease duration, joint inflammation, and previous treatments.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of vildagliptin and placebo, with inclusion criteria such as confirmed diagnosis of T2DM, stable oral anti-diabetic therapy, HbA1c of \u2265 7.5 and \u2264 11.0%, and BMI \u226522 to \u226445 kg/m2.",
    "The sample is a phase 3 trial for patients with bipolar disorder and mania, testing the efficacy of cariprazine and placebo, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of telbivudine and peginterferon alpha-2a in treating chronic hepatitis B in patients who meet specific eligibility criteria, while excluding those with certain medical conditions or drug therapies.",
    "This phase 3 trial is testing the effectiveness of azilsartan medoxomil and amlodipine in treating hypertension, with strict inclusion and exclusion criteria.",
    "This is a phase 3 clinical trial for hypertension patients, testing the efficacy of placebo, valsartan, and fimasartan, with strict inclusion and exclusion criteria.",
    "This is a phase 3 clinical trial for the treatment of idiopathic restless legs syndrome using SPM962 and placebo, with specific inclusion and exclusion criteria, and a list of ICD-10 codes and drugs used in the study.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of fostamatinib and placebo, with inclusion criteria including active RA, use of methotrexate, and swollen/tender joints, and exclusion criteria including pregnancy, liver disease, and previous failure to respond to certain treatments.",
    "The sample is a phase 3 trial for type 2 diabetes, testing saxagliptin and placebo, with inclusion criteria of documented history of CrCl <50 ml/min and HbA1c \u22657.0% and \u226411.0%, and exclusion criteria of previous or current treatment with any DPP-IV inhibitor and/or GLP-1 mimetic.",
    "This is a phase 3 trial for pulmonary hypertension, testing the efficacy of oral treprostinil sustained release tablets versus placebo, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for metastatic or unresectable colorectal cancer using a combination of fluorouracil, irinotecan hydrochloride, leucovorin calcium, and oxaliplatin, with eligibility criteria including measurable disease, ECOG performance status 0-2, and no prior or concurrent CNS metastasis.",
    "This phase 3 trial is testing the efficacy of indacaterol and formoterol, along with their respective placebos, in treating chronic obstructive pulmonary disease (COPD) in patients with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for prostate cancer with the drugs degarelix and goserelin acetate, and the eligibility criteria includes completing the CS35 trial and not being withdrawn from it.",
    "The sample is a phase 2/phase 3 trial for glaucoma patients requiring first time filtering surgery, testing the efficacy of ranibizumab and mitomycin, with inclusion and exclusion criteria listed, and disease identified by icd-10 codes.",
    "This is a phase 3 trial for epilepsy patients, testing the efficacy of brivaracetam with inclusion criteria such as having at least 2 but not exceeding 40 partial onset seizures per 4 weeks and being on a stable dose of 1-2 concomitant Antiepileptic Drugs (AEDs), while exclusion criteria include having seizure type IA non-motor as only seizure type and other serious uncontrolled disease.",
    "This phase 3 trial will test the efficacy of casopitant, dexamethasone, and ondansetron in preventing chemotherapy-induced nausea and vomiting in patients with solid malignant tumors receiving anthracycline and cyclophosphamide, and will exclude patients with certain medical conditions and those taking certain medications.",
    "The sample is a phase 3 trial for smoking cessation, testing the efficacy of placebo and varenicline drugs, with inclusion criteria of stable cardiovascular disease and smoking > 10 cigarettes/day, and exclusion criteria of unstable cardiovascular disease, recent cardiovascular events, and moderate/severe COPD.",
    "The sample is a phase 3 trial for ovarian cancer testing the efficacy of trabectedin, doxil, and dexamethasone in patients who have only received one platinum-based chemotherapy regimen and have progressed more than 6 months after initial treatment, with inclusion and exclusion criteria listed.",
    "This phase 3 trial will test the efficacy of Sativex, a cannabis-based medication, versus placebo in treating peripheral neuropathy pain in patients with underlying conditions such as post herpetic neuralgia, peripheral neuropathy, focal nerve lesion, radiculopathy or Complex Regional Pain Syndrome (CRPS) type 2, who have not found relief with their current therapy, and meet other eligibility criteria.",
    "This phase 3 trial is testing the effectiveness of candesartan cilexetil in treating type 1 diabetes, with inclusion criteria including patients with stable diabetic therapy and exclusion criteria including patients with a history of retinopathy or need for treatment with ACE-inhibitor.",
    "The sample is a phase 3 trial for chronic hepatitis B virus in pediatric patients, testing the efficacy of entecavir and placebo, with specific eligibility criteria including age, viral load, and liver function.",
    "The sample is a phase 3 trial for schizophrenia with ziprasidone and risperidone as the drugs being tested, and the eligibility criteria includes a diagnosis of schizophrenia and a CGI-S score of 4 or less at baseline.",
    "This is a phase 2/phase 3 trial for metastatic colorectal cancer testing the efficacy of mitomycin c, capecitabine, and bevacizumab, with eligibility criteria including age >18, measurable and/or non-measurable disease, and adequate bone marrow, renal, and hepatic function.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of multiple inhalation powders including fluticasone furoate/vilanterol, with specific inclusion and exclusion criteria, and a list of icd-10 codes for asthma.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of exenatide and placebo in patients with specific eligibility criteria, including stable metformin or sulfonylurea therapy and exclusion criteria such as previous participation in exenatide studies or use of weight loss drugs.",
    "The sample is a phase 3 trial for Parkinson's disease using the drug rotigotine, with inclusion criteria for early and advanced idiopathic Parkinson disease with early morning motor impairment and exclusion criteria for atypical Parkinsonian syndromes.",
    "This phase 3 trial is testing the efficacy of lenalidomide and melphalan in treating multiple myeloma patients who meet specific eligibility criteria, including having active multiple myeloma requiring treatment and having stable disease or being responsive to at least 2 months of any induction therapy, while also meeting various health requirements such as having an ECOG performance status of 0-1 and having a DLCO > 50% predicted with no symptomatic pulmonary disease.",
    "The sample is a phase 3 trial for stable schizophrenic patients using Seroquel (quetiapine) with inclusion and exclusion criteria, and the disease being studied is schizophrenia with associated ICD-10 codes.",
    "This phase 3 trial is testing the effectiveness of olodaterol and tiotropium in patients with chronic obstructive pulmonary disease (COPD) who meet specific inclusion and exclusion criteria, including age, smoking history, and ability to perform pulmonary function tests, while excluding those with other significant diseases or taking certain medications.",
    "The sample is a phase 3 trial for the treatment of primary insomnia using suvorexant and a dose-matched placebo, with eligibility criteria including a diagnosis of primary insomnia, ability to complete questionnaires, and exclusion criteria including recent cardiovascular disorder and history of substance abuse/dependence.",
    "The sample is a phase 3 clinical trial for breast cancer patients, testing the effectiveness of a combination of drugs including docetaxel, 5-fluorouracil, doxorubicin, and cyclophosphamide, with specific eligibility criteria for inclusion and exclusion.",
    "The sample is a phase 3 trial for children with atopic dermatitis, testing the efficacy of placebo and levocetirizine as drugs, with inclusion criteria including age, duration of symptoms, and family history of atopy, and exclusion criteria including use of certain medications and other medical conditions.",
    "The sample is a phase 3 trial for surgically incurable melanoma patients, testing the efficacy of temozolomide and dacarbazine, with eligibility criteria including age, performance status, laboratory values, and disease-free period, while exclusion criteria include ocular melanomas, brain metastases, and prior cytokine or chemotherapy for stage IV disease.",
    "The sample is a phase 3 trial for attention deficit hyperactivity disorder, testing the efficacy of atomoxetine hydrochloride and placebo in newly diagnosed patients who meet specific inclusion criteria, with exclusion criteria including a history of ADHD diagnosis longer than 3 months prior to Visit 1 and patients who weigh less than 20 kg at study entry.",
    "The sample is a phase 3 trial for patients with atrial fibrillation or cardiovascular disease, testing the effectiveness of irbesartan and placebo in reducing blood pressure, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is testing the efficacy of prasugrel and aspirin in treating acute coronary syndromes with non-ST-segment elevation and elevated troponin, with eligibility criteria including being scheduled for coronary angiography/PCI and being enrolled at a cardiac catheterization laboratory hospital or affiliated hospital/ambulance service.",
    "The sample is a phase 3 trial for advanced solid tumors and metastatic pancreatic cancer, testing the drugs amg 479 and gemcitabine, with eligibility criteria including untreated metastatic adenocarcinoma of the pancreas and adequate hematologic, renal and liver function.",
    "The sample is a phase 3 trial for familial hypercholesterolemia, testing the efficacy of rosuvastatin and placebo drugs, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for chronic primary insomnia, testing the efficacy of esmirtazapine and placebo, with inclusion and exclusion criteria listed, and icd-10 codes provided for the disease.",
    "The sample is a phase 3 trial for schizophrenia, testing the efficacy of sm-13496 (lurasidone hcl), risperidone, and placebo, with inclusion criteria of meeting DSM-IV criteria for schizophrenia and exclusion criteria of a history of neuroleptic malignant syndrome, Parkinson's disease, or malignancy.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of ta-7284 low, ta-7284 high, and placebo drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of paliperidone er tablets, quetiapine tablets, and placebo in treating schizophrenia, with specific inclusion and exclusion criteria, and the disease is identified by ICD-10 codes F20.0, F20.1, F20.2, F20.3, F20.5, F20.89, and F20.9.",
    "The sample is a phase 3 trial for kidney transplant patients using sirolimus, with inclusion criteria of first-time dialysis patients weighing over 88 pounds, and exclusion criteria of high cholesterol, obesity, and older organ donors.",
    "This phase 3 trial is testing the efficacy of oros methylphenidate hcl, Ritalin, and placebo in treating attention deficit hyperactivity disorder in patients who meet specific inclusion criteria, while excluding those with certain medical conditions or allergies.",
    "This is a phase 3 trial for asthma patients, testing the efficacy of fluticasone furoate/vilanterol and fluticasone furoate, with eligibility criteria including age, FEV1, and reversibility of FEV1, and exclusion criteria including history of life-threatening asthma, respiratory tract infections, and use of certain medications.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus and cardiovascular disease, testing the efficacy of dapagliflozin versus placebo, with inclusion and exclusion criteria based on anti-diabetic treatment and disease control.",
    "The sample is a phase 3 trial for type 2 diabetes testing the efficacy of liraglutide versus placebo in patients with specific inclusion and exclusion criteria, including age, duration of diabetes, A1c levels, and medication use, among others.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of linagliptin and placebo in combination with metformin and a sulphonylurea drug, with specific inclusion and exclusion criteria.",
    "This trial is a phase 2/phase 3 study testing the efficacy of tipranavir, an antiretroviral drug, in HIV-infected patients who have completed a previous tipranavir/ritonavir trial or have confirmed virologic failure in the 1182.12 or 1182.48 trials and are not able to obtain TPV by prescription.",
    "The sample is a phase 3 trial for peripheral neuropathy and HIV infections, using pregabalin as a drug, with specific inclusion and exclusion criteria based on a previous trial.",
    "The sample is a phase 3 trial for women with menorrhagia, testing the efficacy of tranexamic acid tablets (xp12b) in reducing heavy menstrual bleeding, with inclusion criteria of women aged 18-49 with regularly occurring menstrual periods and exclusion criteria of clinically significant disease or abnormalities that might confound the study or history of bilateral oophorectomy or hysterectomy.",
    "The sample is a phase 3 trial for bipolar disorder, testing the efficacy of ziprasidone and placebo, with inclusion criteria requiring a primary diagnosis of Bipolar I Disorder and a Young Mania Rating Scale score of 18 or higher, and exclusion criteria excluding subjects with other DSM-IV-TR Axis I or Axis II disorders and those without active lithium or divalproex treatment.",
    "The sample is a phase 3 trial for patients aged 45 and older with established vascular disease and atherogenic dyslipidemia, testing the efficacy of extended release niacin and simvastatin in reducing LDL-C and increasing HDL-C, with eligibility and exclusion criteria specified.",
    "The sample is a phase 3 trial for locally advanced colorectal cancer patients who underwent complete resection of primary tumor within the past 12 weeks and received neoadjuvant fluoropyrimidine-based chemoradiotherapy with capecitabine and oxaliplatin, and the eligibility criteria include patient characteristics such as WHO performance status, platelet count, and absence of serious uncontrolled medical conditions.",
    "The sample is a phase 3 trial for previously untreated follicular stage III or IV non-Hodgkin's lymphoma, using cyclophosphamide, prednisone, and vincristine sulfate as drugs, with eligibility criteria including age, performance status, and no prior malignancies.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of rimonabant and placebo drugs, with eligibility criteria including age, diagnosis, insulin treatment, and HbA1C levels, and exclusion criteria including weight loss, pregnancy, and history of cancer, among others.",
    "This is a phase 3 clinical trial for children aged 2 to 10 years with mild or moderate acute flare of atopic dermatitis, testing the efficacy of fluticasone cream compared to placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of cisplatin, etoposide, and ifosfamide in treating poor prognosis germ cell cancer patients with specific eligibility criteria, including age, sex, and disease characteristics such as mediastinal primary or nonpulmonary visceral metastases.",
    "The sample is a phase 3 trial for patients with inadequately controlled type 2 diabetes, testing the drug vildagliptin, with inclusion criteria including HbA1c range of \u2265 6.5 to \u2264 10%, and exclusion criteria including type 1 diabetes mellitus and significant heart diseases.",
    "The sample is a phase 3 trial for allergic rhinoconjunctivitis, testing depiquick birch and placebo drugs, with inclusion and exclusion criteria based on medical history and specific IgE against birch allergens.",
    "This phase 3 trial is testing the efficacy of quetiapine fumarate xr and placebo in treating Generalized Anxiety Disorder, with patients meeting specific inclusion and exclusion criteria, and having a history of anxiety disorders with specific ICD-10 codes.",
    "This is a phase 3 trial for breast cancer patients, testing the drug goserelin, with eligibility criteria including premenopausal status, negative hormone-receptor status, and treatment with at least four cycles of chemotherapy.",
    "The sample is a phase 3 trial for insomnia, testing the efficacy of vec-162 at different doses and placebo, with inclusion criteria of healthy subjects and exclusion criteria of prior sleep disorders, night shift work, or sleep lab experience. The icd-10 codes for insomnia are listed as well.",
    "The sample is a phase 3 trial for metastatic castration-resistant prostate cancer, testing the efficacy of abiraterone acetate and prednisone/prednisolone compared to placebo, with eligibility criteria including prior chemotherapy with docetaxel and adequate organ function.",
    "This phase 3 trial is testing the efficacy of ezetimibe and atorvastatin, atorvastatin, and placebo in treating hypercholesterolemia in patients aged 65 or older with specific LDL levels, while excluding patients with certain medical conditions, unstable medication doses, or elevated laboratory values.",
    "This is a phase 3 trial for primary insomnia, testing the efficacy of almorexant, zolpidem, and placebo, with inclusion criteria of adult subjects with primary insomnia and exclusion criteria of any sleep disorder or DSM-IV axis I disorder other than primary insomnia, sleep apnea, restless legs syndrome, daytime napping of more than 1 hour per day, important caffeine consumption, heavy tobacco use, alcohol or drug abuse within 2 years prior to the screening visit, and unwillingness to refrain from drugs, over-the-counter or herbal medication having an effect on sleep or behavior.",
    "The sample is a phase 2/3 trial for hepatocellular carcinoma testing the efficacy of menatetrenone and placebo, with eligibility criteria including age, liver function, and absence of extrahepatic metastasis or portal invasion.",
    "This is a phase 3 trial for the treatment of moderate to severe plaque psoriasis with apremilast and placebo, with eligibility criteria including a diagnosis of chronic plaque psoriasis for at least 12 months and exclusion criteria including recent use of certain psoriasis medications and investigational drugs.",
    "The sample is a phase 3 trial testing the efficacy of cl-108 and placebo in treating pain, nausea, and vomiting after surgical extraction of impacted third molar teeth, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of duloxetine hydrochloride and placebo, with inclusion criteria of previous depressive episode and painful physical symptoms, and exclusion criteria of anxiety disorders and psychotic disorders.",
    "This phase 3 trial is testing the efficacy of tiotropium and olodaterol in patients with chronic obstructive pulmonary disease who meet specific spirometric criteria and have a smoking history of more than 10 pack years.",
    "This phase 3 trial aims to evaluate the efficacy of buprenorphine compared to placebo in treating moderate to severe chronic low back pain in patients taking \u226460 mg oral morphine/day or equianalgesic dose of another opioid, with inclusion and exclusion criteria specified.",
    "This trial is a phase 2/phase 3 study testing the efficacy of SPM 962 and placebo in treating early Parkinson's disease, with specific inclusion and exclusion criteria, such as Hoehn & Yahr stage 1-3 and no previous participation in a trial with SPM 962.",
    "The sample is a phase 3 trial for type 2 diabetes, testing saxagliptin and placebo, with inclusion criteria including age, metformin use, A1C levels, and BMI, and exclusion criteria including pregnancy, cardiovascular history, liver disease, and renal impairment.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease, testing the efficacy of budesonide/formoterol and prednisolone in patients with specific inclusion and exclusion criteria based on pulmonary function tests and clinical examination.",
    "This phase 3 trial is testing the effectiveness of levetiracetam, a drug used to treat drug-resistant epilepsy, in patients who have experienced cluster seizures within the past 24 hours and meet specific inclusion criteria, while excluding patients with certain medical conditions or taking certain medications.",
    "This phase 3 trial is testing the drug gw873140 on HIV-infected patients with specific eligibility criteria, including prior antiretroviral experience and documented resistance to certain drug classes.",
    "The sample is a phase 3 trial for chronic plaque psoriasis, testing the efficacy of placebo, secukinumab, and etanercept, with specific inclusion and exclusion criteria for subjects.",
    "This phase 3 trial is testing the efficacy of multiple drugs, including gsk573719/gw642444 and gw642444 25, on patients with chronic obstructive pulmonary disease (COPD) who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for patients with coronary artery disease, myocardial infarction, and cerebrovascular stroke, testing the effectiveness of folic acid, vitamin B12, and vitamin B6 supplements compared to placebo, with eligibility criteria including adults over 18 years old who have undergone coronary angiography.",
    "The sample is a phase 3 trial for patients with venous thromboembolism, including those with factor V Leiden, who completed anticoagulation therapy within the last two years and are not currently on it, with warfarin as the drug being tested. The trial involves multiple cardiovascular and vascular diseases with corresponding ICD-10 codes.",
    "This phase 3 trial is testing the efficacy of gemcitabine hydrochloride in treating various stages of pancreatic cancer, with strict eligibility criteria including no prior chemotherapy for metastatic disease and no recent arterial thrombotic events.",
    "The sample is a phase 3 trial for prostate cancer with bone metastasis, testing the efficacy of docetaxel, zd4054, and placebo, with eligibility criteria including confirmed diagnosis of prostate cancer, increasing PSA, and current treatment with surgical or medical castration.",
    "This phase 3 trial is testing the drug NGX-4010 for the treatment of post-herpetic neuralgia (PHN) in patients who meet specific eligibility criteria, including having intact skin over the painful area(s) and not taking certain medications, while excluding those with certain medical conditions or recent interventions.",
    "The sample is a phase 3 trial for chronic hepatitis C patients who are non-responders to previous therapy with PEGinterferon alpha plus ribavirin, and will test the efficacy of ribavirin and placebo as drugs, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of sitagliptin phosphate and glimepiride, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for CD20-positive diffuse large B-cell lymphoma, testing the efficacy of bevacizumab, rituximab, chop, and placebo, with inclusion criteria of age, disease type, risk level, and ECOG performance status, and exclusion criteria of prior treatment, non-DLBCL lymphoma types, and CNS involvement.",
    "This is a phase 3 trial for allergic rhinitis, testing the efficacy of bdp nasal aerosol and placebo in children aged 4 to 11 with a history of PAR to a relevant perennial allergen, and with demonstrated sensitivity to at least one allergen known to induce PAR through a standard skin prick test.",
    "The sample is a phase 3 trial for the treatment of benign prostatic hyperplasia using tadalafil and placebo, with inclusion and exclusion criteria related to cardiac and other health conditions.",
    "This phase 3 trial is testing the efficacy of multiple drugs, including bicalutamide and goserelin, in treating locally advanced adenocarcinoma of the prostate, with eligibility criteria including a Gleason score of at least 8 and negative bone scan.",
    "The sample is a phase 3 trial for cystic fibrosis patients, testing the efficacy of mannitol and placebo drugs, with specific eligibility criteria including confirmed diagnosis of cystic fibrosis, FEV1 >30% and <90% predicted, and exclusion criteria such as recent myocardial infarction or cerebral vascular accident, allergy or intolerance to mannitol, and using nebulised hypertonic saline.",
    "The sample is a phase 3 trial for patients with schizophrenia, testing the efficacy of quetiapine fumarate, with inclusion criteria including a clinical diagnosis of schizophrenia and ability to provide informed consent, and exclusion criteria including non-compliance history and lack of response to previous quetiapine treatment.",
    "The sample is a phase 3 trial for patients with completely resected breast cancer, testing the efficacy of exemestane, tamoxifen, and triptorelin as endocrine therapy, with eligibility criteria including hormone receptor positivity and no distant metastases.",
    "This phase 3 trial is testing the drug leuprorelin acetate for locally advanced or relapsing prostate cancer with inclusion criteria such as Gleason score of >=6 and ECOG performance status of 0-2.",
    "The sample is a phase 3 trial for bacterial pneumonia, testing the efficacy of ceftaroline fosamil for injection, iv ceftriaxone, placebo, and clarithromycin, with inclusion and exclusion criteria for subjects.",
    "The sample is a phase 3 trial for non small cell lung cancer, testing the drugs vandetanib and erlotinib, with eligibility criteria including failure of prior chemotherapy regimens and exclusion criteria including prior treatment with certain drugs and recent anti-cancer therapy.",
    "This phase 3 trial is testing the efficacy of retigabine and placebo in treating refractory epilepsy with simple or complex partial onset seizures, with inclusion and exclusion criteria specified.",
    "The trial is a phase 2/phase 3 study testing the efficacy of four drugs (indacaterol, formoterol, tiotropium, and placebo) on patients with moderate to severe chronic obstructive pulmonary disease (COPD) who meet specific inclusion criteria, including a smoking history of at least 20 pack years and post-bronchodilator FEV1 < 80% and \u2265 30% of the predicted normal value.",
    "The sample is a phase 3 trial for previously untreated diffuse large B-cell lymphoma or follicular non-Hodgkin lymphoma patients receiving rituximab plus CHOP or CVP chemotherapy, with eligibility criteria including age \u2265 18 years, ECOG performance status 0-2, and exclusion criteria including clinically significant cardiovascular disease, and patients will be excluded if they have a circulating lymphocyte count > 5,000/\u03bcL before the Cycle 2 rituximab infusion or develop a serious and/or Grade 3 or 4 adverse event during Cycle 1 judged by the investigator to be related to the rituximab infusion.",
    "The sample is a phase 3 trial for patients with acute coronary disease and unstable angina, testing the efficacy of clopidogrel and acetylsalicyclic acid (ASA) as drugs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes with the drugs liraglutide, sitagliptin, and metformin, and the eligibility criteria includes HbA1c levels and BMI, while excluding previous treatment with insulin or other anti-diabetic drugs, serious medical conditions, and pregnancy.",
    "The sample is a phase 3 trial for metastatic colorectal cancer, testing the efficacy of cediranib, folfox, xelox, and cediranib placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for prostate cancer patients with rising PSA levels or progressive soft tissue or bony disease, testing the efficacy of enzalutamide and placebo, with eligibility criteria including ongoing androgen deprivation therapy and exclusion criteria including severe concurrent disease or brain metastasis.",
    "This phase 3 trial is testing the efficacy of vernakalant and amiodarone injections in cardioversion of symptomatic atrial fibrillation patients with specific eligibility criteria.",
    "The sample is a phase 3 trial for metastatic or locally-advanced pancreatic adenocarcinoma, testing the efficacy of AG-013736 and gemcitabine compared to placebo, with inclusion and exclusion criteria listed.",
    "This is a phase 3 trial for saxagliptin and placebo in patients with type 2 diabetes mellitus, with specific inclusion and exclusion criteria, and the trial will test the efficacy of the drugs in controlling blood glucose levels.",
    "This phase 3 trial is testing the effectiveness of propiverine hydrochloride and tolterodine extended-release tablet in treating overactive bladder in patients aged 18 to 65 with urinary frequency, urgency, and/or urge incontinence, and who meet certain inclusion criteria, while excluding patients with certain conditions or who have taken certain medications within a certain period.",
    "This phase 3 trial is testing the effectiveness of carvedilol and valsartan in controlling residual hypertension in subjects who have had adverse effects with ACE inhibitors, have no secondary hypertension, and do not have any other medical conditions that would interfere with optimal participation in the study.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of budesonide/formoterol and budesonide drugs, with inclusion criteria of age, asthma diagnosis, and previous treatment with inhaled corticosteroids, and exclusion criteria of severe asthma and sensitivity to specified drugs or treatment with beta-blockers.",
    "The sample is a phase 3 trial for Parkinson's disease and dyskinesia, testing the efficacy of sarizotan and placebo, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in treating chronic obstructive pulmonary disease (COPD) in patients who meet specific inclusion criteria, including a pre and post-albuterol/salbutamol FEV1/FVC ratio of <0.70 and a pre and post-albuterol/salbutamol FEV1 of FEV1 of <=70% of predicted normal values calculated using NHANES III reference equations at Visit 1.",
    "This phase 3 clinical trial is testing the efficacy of hoe901-u300 and lantus, two insulin glargine formulations, in controlling type 2 diabetes mellitus in adults who are inadequately controlled with non-insulin antihyperglycemic drugs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for acute myeloid leukemia, testing the efficacy of cytarabine or supportive care and dacogen (decitabine) only, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for postmenopausal women with endometrial hyperplasia and osteoporosis, testing the efficacy of bazedoxifene/conjugate estrogens (ce), raloxifene, and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for glaucoma and ocular hypertension, testing the effectiveness of two eye drop solutions (duotrav and cosopt) with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of oxaliplatin based chemotherapy, panitumumab, irinotecan based chemotherapy, and bevacizumab in treating metastatic colorectal cancer patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for chronic hepatitis C, testing the drugs sof, rbv, and placebos, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of vortioxetine and placebo in treating major depressive disorder, with specific inclusion and exclusion criteria for participants.",
    "This is a phase 3 trial for patients with hepatitis B, testing the drug clevudine, with specific eligibility criteria including age, disease status, and exclusion criteria such as previous treatment with certain drugs or co-infection with other viruses.",
    "This phase 3 trial is testing the efficacy of pancrelipase delayed release and placebo comparator in treating cystic fibrosis and pancreatic exocrine insufficiency patients who have confirmed diagnoses and are currently receiving treatment with a stable dose of pancreatic enzyme product for more than 3 months.",
    "This phase 3 trial focuses on renal transplantation and the drug fty720, with inclusion criteria for patients between 18 to 65 years old undergoing primary cadaveric or primary non-HLA identical living donor kidney transplantation, and exclusion criteria for recipients of multi-organ transplantation or foreseen to receive a non-renal allograft during the study period, graft cold ischemia time greater than 40 hours, and patients with pulse rate < 50 beats per minute (bpm) at screening.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of methotrexate, ocrelizumab, and placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for asthma patients using levocetirizine as a drug, with a list of icd-10 codes for asthma, and eligibility criteria including completion of a previous trial.",
    "The sample is a phase 3 trial for unresectable metastatic colorectal cancer using a combination of fluorouracil, irinotecan hydrochloride, leucovorin calcium, and oxaliplatin, with eligibility criteria including ECOG performance status, blood counts, liver function tests, and exclusion criteria including bleeding diathesis, cardiovascular disease, and peripheral neuropathy.",
    "This phase 3 trial aims to test the efficacy of olmesartan medoxomil and candesartan cilexetil placebo in treating chronic heart failure patients with blood BNP levels > 400 pg/ml or NT-ProBNP levels > 1500 pg/ml, who have been stable on conventional treatment with diuretics, ACEI and/or beta-blockers and/or aldosterone antagonists for at least 2 months prior to randomisation, unless documented contraindication or intolerance.",
    "The sample is a phase 3 trial for chronic kidney disease patients on hemodialysis with hyperphosphatemia, testing the efficacy of asp1585 and sevelamer hydrochloride as phosphate binders, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of metformin and LY2189265 compared to placebos, with eligibility criteria including HbA1c levels, BMI, and exclusion criteria including recent use of insulin or GLP-1 analogs, and history of uncontrolled diabetes or organ transplant.",
    "The sample is a phase 3 trial for fibromyalgia, testing the efficacy of placebo and xyrem\u00ae drugs, with inclusion criteria based on ACR diagnostic criteria and exclusion criteria based on rheumatic disease or other disorders that may compromise reliable representation of subjective symptoms.",
    "The sample is a phase 3 clinical trial for patients with Crohn's disease, ulcerative colitis, unclassifiable colitis or pouchitis, who have cytomegalovirus infection and need treatment with corticoids and/or immunosuppressive drugs, using valganciclovir as the drug, with specific inclusion and exclusion criteria."
]